{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T15:56:10Z","timestamp":1772380570399,"version":"3.50.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/jcp.0b013e31823f87ac","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T16:48:34Z","timestamp":1324745314000},"page":"106-109","source":"Crossref","is-referenced-by-count":22,"title":["Effects of Aripiprazole and the Taq1A Polymorphism in the Dopamine D2 Receptor Gene on the Clinical Response and Plasma Monoamine Metabolites Level During the Acute Phase of Schizophrenia"],"prefix":"10.1097","volume":"32","author":[{"given":"Itaru","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Katsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azuma","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaohui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirobumi","family":"Mashiko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Ichi","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210128","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R2-17-20210128","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1176\/appi.ajp.158.5.802","article-title":". Association of short-term response to haloperidol treatment with a polymorphism in dopamine D2 receptor gene.","volume":"158","author":"Schafer","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R3-17-20210128","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.euroneuro.2008.07.010","article-title":". Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.","volume":"18","author":"Kwon","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"R4-17-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1176\/appi.ajp.2009.09040598","article-title":"D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.","volume":"167","author":"Zhang","year":"2010","journal-title":"Am J Psychiatry"},{"key":"R5-17-20210128","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/humu.20039","article-title":"Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1.","volume":"23","author":"Neville","year":"2004","journal-title":"Hum Mutat"},{"key":"R7-17-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1126\/science.6849119","article-title":". Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol.","volume":"219","author":"Kopin","year":"1983","journal-title":"Science"},{"key":"R8-17-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":". Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R9-17-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15622970802309617","article-title":". Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neuroleptic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients.","volume":"2","author":"Yoshimura","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"R10-17-20210128","first-page":"39","article-title":". Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptoms Scale: comparison with Western scale in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.","volume":"18","author":"Inada","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R11-17-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":". Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.","volume":"63","author":"Kane","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R12-17-20210128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":". Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R13-17-20210128","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/ac00126a067","article-title":"Simultaneous determination of free homovanillic acid, (3-methoxy-4hydroxyphenyl)ethylene glycol, and vanilmandelic acid in human plasma by high-performance liquid chromatography coupled with dual-electrode coulometric electrochemical detection.","volume":"58","author":"Gerhardt","year":"1986","journal-title":"Anal Chem"},{"key":"R14-17-20210128","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/hmg\/2.12.2197-a","article-title":"PCR detection of the TaqA RFLP at the DRD2 locus.","volume":"2","author":"Grandy","year":"1993","journal-title":"Hum Mol Genet"},{"key":"R15-17-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","article-title":". 7-4-4-(2,3-dichlorophenyl)-1-piperazinylbutyloxy-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.","volume":"274","author":"Kikuchi","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"R16-17-20210128","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0006-3223(96)00244-2","article-title":"First-episode neuroleptic-free schizophrenics: concentration of monoamines and their metabolites in plasma and correlations with clinical responses to haloperidol treatment.","volume":"41","author":"Nagaoka","year":"1997","journal-title":"Biol Psychiatry"},{"key":"R17-17-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-1781(93)90017-B","article-title":". Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.","volume":"46","author":"Davidson","year":"1993","journal-title":"Psychiatry Res"},{"key":"R19-17-20210128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2133\/dmpk.20.55","article-title":". Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of new antipsychotic aripiprazole.","volume":"20","author":"Kubo","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"R20-17-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.mp.4000532","article-title":". Polymorphism in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.","volume":"4","author":"Jonsson","year":"1999","journal-title":"Mol Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201202000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T15:45:57Z","timestamp":1742139957000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201202000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31823f87ac","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}